Figure 7

Prognostic significance validation of the 18-IRLPS in independent cohorts. (A–C) The time-dependent ROC curves of the IRLPS for predicting overall survival in TCGA-ACC (A), TCGA-CHOL (B), and TCGA-LGG (C). (D–F) Kaplan–Meier survival curves of overall survival between patients with higher and lower risk scores of the IRLPS in TCGA-ACC (D; n = 79), TCGA-CHOL (E; n = 36), and TCGA-LGG (F; n = 506). (G–I) The 1-, 3-, and 5-year ROC curves of the IRLPS for predicting progression-free survival in TCGA-ACC (G), TCGA-CHOL (H), and TCGA-LGG (I). (J–L) Kaplan–Meier survival curves of progression-free survival between patients with higher and lower risk scores of the IRLPS in TCGA-ACC (J), TCGA-CHOL (K), and TCGA-LGG (L).